SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 6 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 6,600,000 | $16,038,000 | 6.11% |
| Perceptive Advisors | 2,915,000 | $6,650,000 | 0.52% |
| Tekla Capital Management LLC | 2,000,000 | $4,826,000 | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 170,000 | $410,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 217,000 | $524,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 50,000 | $121,000 | 0.00% |